Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapeutics: what a difference five decades makes!

R O Day1, M L Mashford

  • 1Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, NSW. R.Day@unsw.edu.au

The Medical Journal of Australia
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review.

Transplantation reviews (Orlando, Fla.)·2021
Same author

Trends, determinants and differences in antibiotic use in 68 residential aged care homes in Australia, 2014-2017: a longitudinal analysis of electronic health record data.

BMC health services research·2020
Same author

Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.

Applied clinical informatics·2018
Same author

Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM).

European journal of clinical pharmacology·2018
Same journal

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

The Medical journal of Australia·2026
Same journal

Striving for Racial Equity in Oral Cancer Research: A Case Study.

The Medical journal of Australia·2026
Same journal

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
Same journal

Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

The Medical journal of Australia·2026
Same journal

Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

The Medical journal of Australia·2026
Same journal

Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

The Medical journal of Australia·2026
See all related articles

Medical treatments have advanced significantly over 50 years, moving beyond symptom relief to disease modification. Advances in genomics and molecular biology promise exponential improvements in targeting disease mechanisms.

Area of Science:

  • Genomic Medicine
  • Molecular Biology
  • Biotechnology

Background:

  • The last 50 years have seen transformative progress in medical capabilities.
  • Historically, medical interventions focused primarily on symptom management.

Observation:

  • Modern medicine's capacity to prevent, cure, or modify diseases has dramatically increased.
  • This evolution is a departure from the traditional approach of solely alleviating symptoms.

Findings:

  • The completion of the Human Genome Project has provided a foundational resource for biological research.
  • Rapid advancements in molecular biology and associated technologies are accelerating progress.

Implications:

  • Future medical interventions will increasingly target specific disease mechanisms at a molecular level.

Related Experiment Videos

  • Personalized medicine approaches will optimize individual responses to treatments.
  • Exponential improvements in healthcare outcomes are anticipated due to these scientific and technological leaps.